These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1142 related items for PubMed ID: 8530330

  • 1. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D, Cowley D, Ries R, Dunner DL, Roy-Byrne PP.
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [Abstract] [Full Text] [Related]

  • 2. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET.
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [Abstract] [Full Text] [Related]

  • 3. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.
    Bizzarri JV, Sbrana A, Rucci P, Ravani L, Massei GJ, Gonnelli C, Spagnolli S, Doria MR, Raimondi F, Endicott J, Dell'Osso L, Cassano GB.
    Bipolar Disord; 2007 May; 9(3):213-20. PubMed ID: 17430295
    [Abstract] [Full Text] [Related]

  • 4. Preliminary observations of DSM-III-R axis I comorbidity in men with paraphilias and paraphilia-related disorders.
    Kafka MP, Prentky RA.
    J Clin Psychiatry; 1994 Nov; 55(11):481-7. PubMed ID: 7989281
    [Abstract] [Full Text] [Related]

  • 5. Anxiety disorders in adults treated by hemodialysis: a single-center study.
    Cukor D, Coplan J, Brown C, Friedman S, Newville H, Safier M, Spielman LA, Peterson RA, Kimmel PL.
    Am J Kidney Dis; 2008 Jul; 52(1):128-36. PubMed ID: 18440682
    [Abstract] [Full Text] [Related]

  • 6. Association of antisocial personality disorder and substance disorder morbidity in a clinical sample.
    Westermeyer J, Thuras P.
    Am J Drug Alcohol Abuse; 2005 Jul; 31(1):93-110. PubMed ID: 15768573
    [Abstract] [Full Text] [Related]

  • 7. Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study.
    Hanel G, Henningsen P, Herzog W, Sauer N, Schaefert R, Szecsenyi J, Löwe B.
    J Psychosom Res; 2009 Sep; 67(3):189-97. PubMed ID: 19686874
    [Abstract] [Full Text] [Related]

  • 8. Comorbidity of axis I psychiatric disorders in bulimia nervosa.
    Brewerton TD, Lydiard RB, Herzog DB, Brotman AW, O'Neil PM, Ballenger JC.
    J Clin Psychiatry; 1995 Feb; 56(2):77-80. PubMed ID: 7852257
    [Abstract] [Full Text] [Related]

  • 9. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders.
    McEvoy PM, Shand F.
    J Anxiety Disord; 2008 Aug; 22(6):1087-98. PubMed ID: 18164585
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M, Mandelli L, Di Nicola M, Harnic D, Catalano V, Tedeschi D, Martinotti G, Colombo R, Bria P, Serretti A, Janiri L.
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [Abstract] [Full Text] [Related]

  • 12. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD, Lubman DI, Cosgrave EM, Killackey EJ, Yuen HP, Hides L, Baksheev GN, Buckby JA, Yung AR.
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [Abstract] [Full Text] [Related]

  • 13. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH, Dunner DL.
    Depress Anxiety; 2008 Nov; 25(2):91-7. PubMed ID: 17311265
    [Abstract] [Full Text] [Related]

  • 14. Depression in adults with intellectual disability: symptoms and challenging behaviour.
    Hurley AD.
    J Intellect Disabil Res; 2008 Nov; 52(11):905-16. PubMed ID: 18680532
    [Abstract] [Full Text] [Related]

  • 15. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C, Schulberg HC, Shear MK.
    Anxiety; 1996 Nov; 2(5):210-8. PubMed ID: 9160625
    [Abstract] [Full Text] [Related]

  • 16. Relation between depression and anxiety in dystonic patients: implications for clinical management.
    Moraru E, Schnider P, Wimmer A, Wenzel T, Birner P, Griengl H, Auff E.
    Depress Anxiety; 2002 Nov; 16(3):100-3. PubMed ID: 12415533
    [Abstract] [Full Text] [Related]

  • 17. Anxiety disorders among patients with co-occurring bipolar and substance use disorders.
    Kolodziej ME, Griffin ML, Najavits LM, Otto MW, Greenfield SF, Weiss RD.
    Drug Alcohol Depend; 2005 Nov 01; 80(2):251-7. PubMed ID: 15876498
    [Abstract] [Full Text] [Related]

  • 18. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
    Graystone HJ, Garner MJ, Baldwin DS.
    J Affect Disord; 2009 Apr 01; 114(1-3):305-9. PubMed ID: 18656267
    [Abstract] [Full Text] [Related]

  • 19. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F, Martin-Guehl C, Maurice-Tison S, Bouvard MP.
    Encephale; 2003 Apr 01; 29(5):391-400. PubMed ID: 14615688
    [Abstract] [Full Text] [Related]

  • 20. Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders.
    Bizzarri JV, Rucci P, Sbrana A, Gonnelli C, Massei GJ, Ravani L, Girelli M, Dell'osso L, Cassano GB.
    Addict Behav; 2007 Feb 01; 32(2):384-91. PubMed ID: 16797139
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 58.